EUCTR2005-000817-37-GB进行中（未招募）1 期
A Study On The Efficacy Of Delta-9-Tetrahydrocannabinol (Dronabinol) In Renal Itch
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Patients with chronic renal failure treated with continuous ambulatory peritoneal dialysis (CAPD) with a history of pruritis for more than 8 weeks.
- •Patients with haemoglobin level =11g/dl.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with concomitant dermatological disease or another metabolic cause of itch.
- •Patients with history of poor concordance
- •Patients who are pregnant, planning to conceive or refuse to take adequate precaution to avoid pregnancy
- •History of psychotic illnesses, schizophrenia, and any other mental illnesses. Mild depression will not be exclude participation but severe depression requiring electroconvulsive therapy (ECT) or inpatient treatment will be excluded
- •Patients who refuse to abstain from driving during the study
- •Those with a history of allergy to delta-9-THC or its related compounds or constituents of dronabinol
- •Patients with unstable cardiac diseases such as uncontrolled hypertension, acute coronary syndrome and uncontrolled arrythmia as delta-9-THC may cause hypo- or hypertension and tachycardia. However, patients with stable cardiac conditions will not be excluded.
研究者
相似试验
已完成
2 期
Efficacy and safety of delta-9-tetrahydrocannabinol (delta-THC) in behavioural disturbances in dementiaAlzheimer's diseaseDementiaNL-OMON39470niversitair Medisch Centrum Sint Radboud150
进行中（未招募）
1 期
THC in behavioural problems and pain in dementiaSubjects with mild to severe Alzheimer's dementia and/or vascular dementia with behavioural disturbances, with at least agitation, aggression or aberrant motor disturbances.MedDRA version: 16.1Level: PTClassification code 10012271Term: Dementia Alzheimer's typeSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 16.1Level: PTClassification code 10057678Term: Vascular dementiaSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 16.1Level: PTClassification code 10033371Term: PainSystem Organ Class: 10018065 - General disorders and administration site conditionsMedDRA version: 16.1Level: PTClassification code 10012267Term: DementiaSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 16.1Level: PTClassification code 10066842Term: Behavioural and psychiatric symptoms of dementiaSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2011-005289-39-NLRadboud university medical center150
已完成
不适用
The effect of delta-9-tetrahydrocannabivarin (THCV) on delta-9-tetrahydrocannabinol (THC)Cannabis elicited psychopathology and cognitive impairmentMental and Behavioural DisordersMental and behavioural disorders due to use of cannabinoidsISRCTN93423464King's College London (UK)10
进行中（未招募）
不适用
The Effects of Delta 9-tetrahydrocannabinol (THC) on Driving Performance, Cognition, Fatigue and Stress.ACTRN12611000030976Securetec20
已完成
不适用
The effects of inhaled delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on pain relief and subjective effects in fibromyalgia patients - A placebo controlled PKPD studychronische pijnchronic painpainNL-OMON42607eids Universitair Medisch Centrum20